ABSTRACT
INTRODUCTION
In many pathological conditions associated with vascular lesion formation the production of reactive oxygen species (ROS) is increased in the vessel wall. As a consequence, nitric oxide bioavailability is decreased, due in large part to its rapid reaction with superoxide (O 2
•-
). In addition, it is now clear that ROS may have important intracellular signaling properties. As an example, hydrogen peroxide (H 2 O 2 ) has been shown to modulate eNOS protein expression in vitro (6) . This upregulation of eNOS by H 2 O 2 may occur in pathological conditions such as hypercholesterolemia and hypertension where both O 2
•-and increased eNOS expression have been observed (12), (1) .
Major sources of ROS in vascular cells are the NADPH oxidases, multi-subunit enzyme complexes similar to the phagocytic oxidase. In phagocytic cells, NADPH oxidases consist of the catalytic gp91 phox and p22 phox subunits. Recently, it has been recognized that gp91 phox is a member of a larger family of Nox proteins, and it has been renamed Nox2. The vascular smooth muscle cells (VSMC) NADPH oxidases differ from the phagocytic enzyme in that they utilize Nox1 and Nox4, and larger vessels do not contain Nox2 (16) . However, all NADPH oxidases utilize p22 phox , which plays an important role as a docking protein for the cytoplasmic subunits and as a stabilizer of Nox protein expression (15) . The vascular NADPH oxidases can be activated by a variety of pathophysiological stimuli, including angiotensin II (AII) (16) . In addition, over several days, AII increases expression of p22 phox , Nox1 and Nox4. Previously, we have found that during angiotensin II-induced hypertension, the time course of increased NADPH oxidase activity and blood pressure paralleled that of an increase in p22 phox (18) , suggesting that this subunit may have an important role in the modulation of overall enzyme activity. In cultured VSMC, inhibition of p22 phox expression using antisense techniques inhibits hypertrophy caused by angiotensin II (22). Moreover, polymorphisms of p22 phox have been variably associated with an increase in cardiovascular events, a reduction in endotheliumdependent vasodilatation and an increase in coronary atherosclerosis. Intimal VSMC in atherosclerotic lesions contain large amounts of p22 phox that co-localizes with sites of O 2
•-production (21).
Given this apparent importance of p22 phox , we sought to determine if increasing its expression in vivo would alter vascular ROS production, and to understand how this would affect hemodynamics and endothelium-dependent vasodilatation, by directing expression of p22 phox to smooth muscle in transgenic mice. Our initial characterization of these mice showed that their vessels indeed produced excessive O 2 •-and H 2 O 2 , but their endothelium-dependent vasodilatation and blood pressure were normal. Additional studies indicated that expression of eNOS and the extracellular superoxide dismutase (ecSOD) was increased. We propose that compensatory responses such as an increase in expression of eNOS and ecSOD are critical in the setting of oxidative stress, and that overt vascular dysfunction does not occur until these fail.
METHODS

Animals:
Mice overexpressing the NADPH oxidase p22 phox subunit in VSMC (Tg p22smc mice)
were created by cloning the p22 phox cDNA downstream of the smooth muscle cells-targeted SMP-8 promoter and upstream of a SV40polyA fragment ( figure 1A ). The Sph1-Kpn1 fragment was used for oocyte injection. Several founder Tg p22smc mice were obtained that were able to transmit the transgene to offspring. They were backcrossed at least 10 times to the C57BL/6J
background. C57BL/6J mice were used as controls. Blood pressure was measured using telemetry (Data Sciences International, MN, USA), as described previously (4) . In some experiments, the NOS inhibitor L-NAME was given in the drinking water (100mg/kg/day). In other experiments, the glutathione peroxidase mimetic ebselen (10mg/kg/day, in 50% DMSO) was infused chronically via an osmotic minipumps (Alzet , Durect corporation, CA, USA)
implanted subcutaneously. As an alternative approach for H 2 O 2 scavenging we crossed Tg p22smc mice with mice overexpressing catalase driven by the Tie-2 promoter (Tg p22phox/catalase ). On the day of study, the animals were killed using CO 2 inhalation and the thoracic aortas removed and dissected free of adherent tissues.
Vascular reactivity: Thoracic aortas were cut into 3 to 4-mm ring segments, and mounted for isometric tension recording in a water-jacketed organ bath (14) . Passive tension was adjusted to 1 gram and vessels were preconstricted with 2 µM PGF2 . Relaxations to cumulative concentrations of acetylcholine were examined.
Determination of aortic O 2
•-and H 2 O 2 : Extracellular O 2 •-release was measured using the SOD-inhibitable cytochrome c reduction assay as previously described (14) . We also measured the expression of SOD proteins by Western blot. Of the 3 SOD isoforms, ecSOD was increased in Tg p22smc mice by 2 fold (figure 2D). and NO production in these animals. NO production was increased by two-fold in aortas of Tg p22smc mice under basal conditions and by more than 7-fold in response to the calcium ionophore A23187 (10µM, figure 4A ). eNOS protein was 2-fold higher in Tg p22smc mice ( figure   4B ).
Effect of p22
To further investigate a link between H 2 O 2 and eNOS protein upregulation, we treated mice for 7 days with ebselen to scavenge H 2 O 2 . Ebselen treatment decreased aortic H 2 O 2 production in both control and Tg p22smc mice (figure 5A). Moreover, ebselen infusion decreased eNOS protein expression in both the Tg p22smc and the C57BL/6J mice (figure 5B figure 5C ).
Effect of NO on ecSOD protein expression:
The above data indicate that overexpression of p22 phox in smooth muscle increased eNOS expression, NO production and ecSOD protein expression. Previously, we have found that NO is a potent stimulus for ecSOD protein expression in vitro.(9). We next determined if increased NO production in Tg p22smc mice underlies the increased ecSOD expression. L-NAME treatment (100 mg/kg/day) for 14 days significantly increased blood pressure in C57BL/6J and Tg p22smc mice (figure 6A), and abolished basal and stimulated NO production (figure 6B). L-NAME also significantly decreased ecSOD protein expression in Tg p22smc mice, but not in C57BL/6J mice ( figure 6C ).
DISCUSSION
In this study, we sought to determine if increasing smooth muscle expression of p22 phox would enhance vascular ROS production, and to examine the effect this has on endothelium-dependent vasodilatation and hemodynamics. We found that aortas of Tg p22smc mice produce increased O 2
•-
and H 2 O 2 , but have no change in endothelium-dependent vasodilatation or hemodynamics.
Tg p22/smc mice also had a striking increase in vascular NO production, eNOS expression and an increase in ecSOD expression. Based on studies using L-NAME, an inhibitor of NO production, that NO is a potent stimulus for ecSOD production in VSMC via a cGMP-dependent pathway (9). It is likely that increased NO production in the Tg p22smc mice is in part responsible for the increased ecSOD production as L-NAME treatment completely abrogated this increase while having no effects on control mice. In our previous study, we showed that ecSOD levels are reduced and not increased by exercise training in eNOS-deficient mice (9). The present study demonstrates that a chronic increase in NO can have the opposite effect, i.e. stimulating ecSOD expression.
One of the major findings of this study is that the resulting increase in H 2 O 2 observed in Tg p22smc mice is associated with an increased eNOS protein expression and NO production. Our group has shown that H 2 O 2 upregulates eNOS mRNA and protein expression, as well as eNOS protein activity (3, 6) , through a Ca 2+ /Calmodulin kinase II and Janus kinase 2-dependent mechanism (2). In these experiments, we used the glutathione peroxidase mimetic ebselen to reduce H 2 O 2 .
Ebselen has been shown to inhibit lipoxygenases, NO synthases, and protein kinase C and to prevent apoptosis (19) . angiotensin II can stimulate both increased ecSOD and NO production (3, 10) , and at least in some models of hypercholesterolemia (17), eNOS expression is increased. In many instances, these compensatory mechanisms may preserve normal vascular function, as in Tg p22smc mice.
The failure of these compensatory mechanisms are therefore likely responsible for development of vascular dysfunction and initiation of disease. Asterisks indicate significant differences (*P<0.05, **P<0.01, t-test). 
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